MOCO, NHPR, HLIT, PWRM, OCLR - Weekend Stock Market Update and News From Stock-PR.com!!

________________________________________

MOCON Inc. (Nasdaq:MOCO) reported its operating results for the fourth quarter and year ended December 31, 2010. Net sales for the fourth quarter 2010 were $9,355,000, a new record for the Company, and an increase of 26 percent compared to $7,444,000 for the fourth quarter 2009. Operating income increased 30 percent to $1,966,000 for the fourth quarter 2010 compared to $1,507,000 for the same period last year. Net income for the fourth quarter 2010 was $1,476,000, a 32 percent increase compared to $1,122,000 in the fourth quarter 2009. Diluted earnings per share were $0.27 in the fourth quarter 2010 compared to $0.21 for the same period in 2009. Net sales for the year 2010 were $31,549,000, also a new record, and an increase of 18 percent compared to $26,638,000 for the year ended December 31, 2009. Operating income increased 51 percent to $5,834,000 for the year 2010 compared to $3,863,000 for the same period prior year. Net income and diluted earnings per share were $4,518,000 and $0.84, respectively, for the year 2010, increases of 55 percent and 58 percent, respectively, compared to $2,910,000 and $0.53 for the year 2009.

MOCON, Inc. develops, manufactures, markets, and services measurement, analytical, and monitoring products that are used to detect, measure, and analyze gases and chemical compounds; and provides related consulting services.

***********************

National Health Partners, Inc. (OTCBB:NHPR)

National Health Partners, Inc., a leading provider of unique discount healthcare membership programs, recently announced that NHPR has achieved positive earnings for the quarter ended September 30, 2010 compared to a loss of $522,542 for the same period last year. Revenues for the 3rd quarter grew 12.3% over the same period last year. NHPR attributes the net earnings to the significant cost-cutting initiatives taken over the past couple of quarters and which is continuing in the 4th quarter.

“I am thrilled to announce that we have finally achieved profitability,” stated David M. Daniels, President and Chief Executive Officer of NHPR. “Due to the fact that our limited medical provider unexpectedly decided to exit the marketplace, we were unable to add any new CARExpress Plus limited medical sales during the 3rd quarter. Yet, despite this temporary setback, we were still able to substantially increase our revenue and reach profitability which is a testament to the underlying strength we have with our core CARExpress health discount programs. Although we achieved positive results in revenues and earnings, we anticipate much better results going forward into 2011.”

Mr. Daniels further states “We are seeing continuous growth during the current 4th quarter which should provide strong momentum for the 1st quarter of 2011. Our future has never looked brighter and I am quite confident that we will be able to see accelerating growth in both revenues and earnings. With our continued focus on keeping our operating costs down while at the same time building our revenues at an accelerating rate, we are in a very good position to see very strong earnings growth going forward. I will be providing more information on new business ventures in the very near term that will change the entire complexion of the company and I look forward to continuing to build on the success that we have already started achieving in the 3rd quarter.”

National Health Partners, Inc. is a national healthcare savings organization that provides discount healthcare membership programs to uninsured and underinsured people through a national healthcare savings network called “CARExpress.” CARExpress is one of the largest networks of hospitals, doctors, dentists, pharmacists and other healthcare providers in the country and is comprised of over 1,000,000 medical professionals that belong to such PPOs as CareMark and Aetna. NHPR’s primary target customer group is the 47 million Americans who have no health insurance of any kind. NHPR’s secondary target customer group includes the millions of Americans who lack complete health insurance coverage. NHPR is headquartered in Horsham, Pennsylvania.

To learn more about NHPR visit: http://www.nationalhealthpartners.com

***********************

Harmonic Inc. (Nasdaq:HLIT) introduced Omneon Spectrum™ MediaCenter, a new multichannel media server with integrated low-cost storage and support for Spectrum MediaPort modularity and scalability. Designed specifically for the needs of local and regional broadcast stations, as well as remote playout facilities, MediaCenter delivers exceptional value for operations requiring from four to 12 channels in a single video server configuration.

Harmonic Inc. designs, manufactures, and sells video products and system solutions that enable service providers to deliver broadcast and on-demand services.

***********************

Power3 Medical Products, Inc. (PWRM.OB)

Power3 Medical Products, Inc., a leading proteomics company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases, recently announced PWRM management believes it is making great progress in its focus on the development, sales, and marketing of its proprietary innovate diagnostic tests for breast cancer, pancreatic cancer, ovarian cancer, colon cancer, and certain neurodegenerative diseases, such as ALS, Alzheimer’s and Parkinson’s, to name a few.

Parkinson’s disease is a disorder of the brain that leads to shaking (tremors) and difficulty with walking, movement, and coordination.
Causes, incidence, and risk factors

Parkinson’s disease most often develops after age 50. It is one of the most common nervous system disorders of the elderly. Sometimes Parkinson’s disease occurs in younger adults. It affects both men and women.

In some cases, Parkinson’s disease occurs in families. When a young person is affected, it is usually because of a form of the disease that runs in families.

Nerve cells use a brain chemical called dopamine to help control muscle movement. Parkinson’s disease occurs when the nerve cells in the brain that make dopamine are slowly destroyed. Without dopamine, the nerve cells in that part of the brain cannot properly send messages. This leads to the loss of muscle function. The damage gets worse with time. Exactly why these brain cells waste away is unknown.

Parkinson’s in children may occur because the nerves are not as sensitive to dopamine. Parkinson’s is rare in children.

The term “parkinsonism” refers to any condition that involves the types of movement changes seen in Parkinson’s disease. Parkinsonism may be caused by other disorders (such as secondary parkinsonism) or certain medications.

Power3 Medical Products, Inc. is a leading bio-technology company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (commonly known as ALS or Lou Gehrig’s disease). Power3 applies proprietary methodologies to discover and identify protein biomarkers associated with diseases. Through these processes, Power3 has developed a portfolio of products including BC-SeraPro, a proteomic blood serum test for the early detection of breast cancer for which it has completed Phase I clinical trials, and NuroPro, a proteomic blood serum test for the detection of neurodegenerative diseases, including Alzheimer’s, Parkinson’s, and ALS diseases, for which it is currently engaged in Phase II clinical trials. These tests are designed to analyze an individual’s proteins to detect the presence of disease, a patient’s disease progression, a patient’s response to a particular drug, and the mechanisms of disease present in the patient for optimal targeted therapy.

To learn more about PWRM visit: http://www.Power3Medical.com

***********************

Oclaro, Inc. (Nasdaq:OCLR) a tier-one provider of optical communications and laser solutions, announced that it will be previewing its latest high-speed optical network components and solutions at private customer suites (booth #2156 and 2160) during the OFC/NFOEC show in Los Angeles next week. As the market leader in high-speed optical networking, the company is the volume shipment leader in 40G DPSK line side 300-pin transponders. During OFC, Oclaro plans to announce its next generation 40G products with plans to extend leadership into the emerging 100G space.

Oclaro, Inc. designs, manufactures, and markets optical components, modules, and subsystems that generate, detect, amplify, combine, and separate light signals in telecommunications networks.

___

**************************************************************

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Stock-PR.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold Stock-PR.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://stock-pr.com/disclaimer). Crown Equity Holdings Inc. (CRWE.OB) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period. Crown Equity Holdings Inc. (CRWE.OB) has received 3,000,000 shares of (144) restricted common stock from the company and 3,000,000 shares of free trading shares from a third party (PIERRE BESUCHET) for six months of advertisement services for National Health Partners Inc. (NHPR.OB). Crown Equity Holdings Inc. (CRWE.OB) has received 1,000,000 shares 144 restricted stocks for IT department services and 2,000,000 shares (free trade) for 12 months of video production from Power 3 Medical Products Inc. (PWRM.OB).

Keywords: , ALS, alzheimers, amyotrophic, BC-SeraPro, biotechnology, cancer, CARExpress, Dan Gambardello, David M Daniels, discount healthcare membership, Ed Pettola, Harmonic, health insurance, Helen Park, HLIT, Ira Goldknopf, MOCO, MOCON, NASDAQ:HLIT., Nasdaq:MOCO, NASDAQ:OCLR, National Health Partners, National HealthCare, NHPR, NHPR.OB, Novartis, NuroPro, Oclaro, OCLR, OTCBB:PWRM, Parkinsons, power3 medical, proteomics, pwrm, PWRM.OB, reduce healthcare costs, Rozetta-Cell, stem cells, underinsured, uninsured, Xpress Healthcare